You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

long acting muscarinic antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Retrospective rEal-life daTa Study to Assess exaceRbations and

Completed
  • COPD
  • COPD Exacerbation
    • Thessaloniki, Greece
      Papanikolaou Hospital of Thessaloniki
    Sep 7, 2022

    COPD Trial in Llanelli (Any LABA/LAMA)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Any LABA/LAMA
    • Llanelli, Carmarthenshire, United Kingdom
      Prince Philip Hospital
    Aug 2, 2022

    Severe Chronic Obstructive Pulmonary Disease inReal World

    Completed
    • Chronic Obstructive Pulmonary Disease
    • beclomethasone / formoterol / glycopyrronium
    • Antwerp, Belgium
    • +14 more
    Nov 25, 2021

    Pulmonary Disease, Chronic Obstructive Trial in Brussels (LABA, LAMA)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Brussels, Belgium
      Erasme University Hospital
    Jun 23, 2023

    Spiolto® Respimat® Versus Triple Combination Therapy in Everyday

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist
    • Triple combination of Free or fixed Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist + inhalative corticosteroids
    • Bad Sachsa, Germany
    • +74 more
    Nov 10, 2021

    COPD Exacerbation Trial in Copenhagen (Long acting muscarinic antagonists (LAMAs) at bedtime)

    Recruiting
    • COPD Exacerbation
    • Long acting muscarinic antagonists (LAMAs) at bedtime
    • Copenhagen, Denmark
      Herlev-Gentofte Hospital
    Jan 30, 2023

    ive Alzheimer's Medicines - Salbutamol vs Long-acting Muscarinic

    Active, not recruiting
    • Chronic Obstructive Pulmonary Disease
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 11, 2022

    South Korea Using Medical Records to Look at Different

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Long-acting Muscarinic Antagonists (LAMA)
    • Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
    • Seoul, Korea, Republic of
      Konkuk University Medical Center
    Feb 8, 2022

    Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Taiwan, China
      Health Data Research Center, National Taiwan University
    Jan 3, 2023

    Pulmonary Disease, Chronic Obstructive Trial in Italy (Bronchodilator Agents)

    Terminated
    • Pulmonary Disease, Chronic Obstructive
    • Bronchodilator Agents
    • Bari, BA, Italy
    • +38 more
    Dec 23, 2022

    Endometriosis Trial in Tirana, Sofia, Rome (degarelix, goserelin)

    Completed
    • Endometriosis
    • Tirana, Albania
    • +2 more
    Feb 10, 2022

    Tiotropium and Olodaterol in Comparison to Triple Therapy

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Tiotropium and Olodaterol (Tio+Olo)
    • Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)
    • Andover, Massachusetts
      HealthCore, Inc.
    Nov 12, 2021

    Asthma, Corticosteroid Trial in Incheon (Oral corticosteroids)

    Not yet recruiting
    • Asthma
    • Corticosteroid
    • Oral corticosteroids
    • Incheon, Gyeongki, Korea, Republic of
      Incheon St. Mary's Hospital
    Mar 3, 2023

    Pulmonary Disease, Chronic Obstructive Trial in United States (Stiolto Respimat, ICS (Inhaled Corticosteroid) (Triple therapy),

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Stiolto Respimat
    • +3 more
    • Mobile, Alabama
    • +89 more
    May 24, 2022

    COPD, Acute Respiratory Failure Trial in Los Angeles, Santa Monica (Revefenacin Inhalation Solution [Yupelri], Ipratropium

    Recruiting
    • COPD
    • Acute Respiratory Failure
    • Revefenacin Inhalation Solution [Yupelri]
    • Ipratropium Bromide
    • Los Angeles, California
    • +1 more
    Sep 3, 2022

    Patterns and Patient Reported Outcome in COPD (REMIND)

    Not yet recruiting
    • COPD
      • (no location specified)
      Jun 12, 2023

      Realize the Current Situation of COPD Patients in China

      Completed
      • Chronic Obstructive Pulmonary Disease COPD
        • Beijing, China
          Research Site
        Jan 11, 2022

        A Multicentre, Prospective, Non-interventional Trial Monitoring

        Not yet recruiting
        • ASTHMA
        • Non-interventional
        • (no location specified)
        Feb 6, 2023

        COPD Trial in Guangzhou (Ensifentrine, Placebo)

        Not yet recruiting
        • Chronic Obstructive Pulmonary Disease
        • Guangzhou, Guangdong, China
          1st Affiliated Hospital of Guangzhou Medical University
        Feb 28, 2023

        COPD, Coronary Artery Calcification Trial (Educational material and treatment recommendations for patients, general

        Not yet recruiting
        • COPD
        • Coronary Artery Calcification
        • Educational material and treatment recommendations for patients, general practitioners and pharmacists
        • (no location specified)
        Dec 1, 2022

        Pathways of Asthma Patients Treated WithExtrafine ICS/LABA/LAMA

        Recruiting
        • Asthma
        • Non-interventional
        • Durham, County Durham, United Kingdom
          The Haven Surgery, The Haven, Burnhope,
        Jul 20, 2022

        Based on Health Insurance Data About Treatment of Been Newly

        Completed
        Has Results
        • Pulmonary Disease, Chronic Obstructive
          • Wismar, Germany
            Institute for pharmacoeconomics and pharmaceutical logistics e.V
          Feb 10, 2022

          COPD Trial in Miami (Bevespi, Bretzri)

          Recruiting
          • Chronic Obstructive Pulmonary Disease
          • Miami, Florida
            University of Miami
          Jan 23, 2023

          Real-life: Impact on Adherence and Health Status (TRITRIAL)

          Completed
          • COPD
          • BDP/FF/G fixed combination
          • Rome, Italy
            Fondazione Policlinico Gemelli
          May 4, 2022

          Chronic Obstructive Pulmonary Disease (COPD) Participants

          Recruiting
          • Pulmonary Disease, Chronic Obstructive
          • prospective observational cohort study
          • Hannover, Niedersachsen, Germany
            GSK Investigational Site
          Jun 20, 2022